RxDoctor Payments Data

Jesse Pace, DO

Family Medicine · Old Fort, NCNPI 1598027765

Payments from drug & device makers

$2,573in general payments, 2019–2025

Across 137 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$417
  • AbbVie$321
  • Novo Nordisk$294
  • Lilly USA, LLC$235
  • Axsome Therapeutics, Inc.$233
  • GSK$187
  • plus $887 from 17 others

What the payments were for

  • Food & beverage$2,573100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,573 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$93,042
Medicare patients
175
Services billed
1,264

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide71$97,751
EliquisApixaban67$75,466
Trelegy ElliptaFluticasone/Umeclidin/Vilanter81$66,985
MounjaroTirzepatide58$65,509
VraylarCariprazine Hcl20$28,829
RybelsusSemaglutide17$28,261
XareltoRivaroxaban41$28,054
TrulicityDulaglutide27$25,087
ArexvyRsvpref3 Antigen/As01e/Pf52$16,353
Tresiba Flextouch U-100Insulin Degludec23$14,138
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$6,508
Lantus SolostarInsulin Glargine,hum.Rec.Anlog46$6,278
ShingrixVaricella-Zoster Ge/As01b/Pf24$5,327
SymbicortBudesonide/Formoterol Fumarate11$3,875
Albuterol Sulfate HfaAlbuterol Sulfate84$2,650

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$294$126,01288 claims
GSKTrelegy Ellipta, Arexvy, Anoro Ellipta, Shingrix$187$95,174171 claims
Lilly USA, LLCMounjaro, Trulicity$235$90,59685 claims
PfizerEliquis$115$75,46667 claims
AbbVieVraylar$321$28,82920 claims
AstraZenecaSymbicort$417$3,87511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Old Fort

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →